
AtriCure ATRC
$ 40.55
0.02%
Quarterly report 2025-Q2
added 07-30-2025
AtriCure Book Value 2011-2025 | ATRC
Book value is a financial metric that reflects the value of a company's assets minus its liabilities as of a specific date, according to accounting records. In simple terms, it is the amount that would remain for the owners of the company if all assets were sold and all debts paid off.What is included in book value
- Assets — all company resources: real estate, equipment, inventory, cash, accounts receivable, and others.
- Liabilities — all debts and financial obligations: loans, accounts payable, taxes, and other obligations.
- Assessment of the company's "real" value
Book value shows how much the company is worth according to accounting data, that is, the value of its property taking debts into account. - Comparison with market capitalization
Comparing book value and the market price of shares helps to understand whether the company is overvalued or undervalued by the market. - Indicator of financial stability
If the book value is high, it indicates the company has significant assets, which reduces risks for investors. - Key component for financial ratios
Many metrics, such as the price-to-book ratio (P/B), use book value to analyze the attractiveness of shares.
Annual Book Value AtriCure
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 461 M | 466 M | 457 M | 484 M | 412 M | 247 M | 249 M | 161 M | 168 M | 187 M | 133 M | 72.6 M | 12.5 M | 15.6 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 484 M | 12.5 M | 252 M |
Quarterly Book Value AtriCure
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 464 M | 455 M | 461 M | 465 M | 462 M | 456 M | 466 M | 463 M | 462 M | 455 M | 457 M | 450 M | - | 463 M | 484 M | 488 M | 385 M | 391 M | 412 M | 412 M | 412 M | 412 M | 247 M | 247 M | 247 M | 247 M | 249 M | 249 M | 249 M | 249 M | 161 M | 161 M | 161 M | 161 M | 168 M | 168 M | 168 M | 168 M | 187 M | 187 M | 187 M | 187 M | 133 M | 133 M | 133 M | 133 M | 72.6 M | 72.6 M | 72.6 M | 72.6 M | 12.5 M | 12.5 M | 12.5 M | 12.5 M | 15.6 M | 15.6 M | 15.6 M | 15.6 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 488 M | 12.5 M | 252 M |
Book Value of other stocks in the Medical instruments industry
| Issuer | Book Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Baxter International
BAX
|
7.02 B | $ 19.11 | 0.95 % | $ 9.75 B | ||
|
Becton, Dickinson and Company
BDX
|
55.3 B | $ 196.12 | 0.23 % | $ 56.4 B | ||
|
Ekso Bionics Holdings
EKSO
|
12.7 M | $ 5.47 | 3.01 % | $ 110 M | ||
|
Luminex Corporation
LMNX
|
199 M | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
76.5 M | - | -9.52 % | $ 20.6 M | ||
|
Antares Pharma, Inc.
ATRS
|
257 M | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
411 M | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
762 M | - | - | $ 282 M | ||
|
iRhythm Technologies
IRTC
|
90.9 M | $ 175.8 | -1.49 % | $ 5.48 B | ||
|
Isoray
ISR
|
291 M | - | 0.03 % | $ 108 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
388 M | - | -0.05 % | $ 10.3 B | ||
|
Repro Med Systems
KRMD
|
20.4 M | $ 6.48 | -0.61 % | $ 295 M | ||
|
Harvard Bioscience
HBIO
|
73.1 M | $ 0.73 | 0.64 % | $ 31 M | ||
|
LeMaitre Vascular
LMAT
|
337 M | $ 84.34 | 0.44 % | $ 1.89 B | ||
|
Varian Medical Systems, Inc.
VAR
|
66.7 M | - | -0.02 % | $ 16.3 B | ||
|
ICU Medical
ICUI
|
4.2 B | $ 146.98 | -0.35 % | $ 3.58 B | ||
|
Alcon
ALC
|
21.6 B | $ 80.17 | 0.06 % | $ 40.4 B | ||
|
Merit Medical Systems
MMSI
|
1.38 B | $ 87.39 | -0.27 % | $ 5.09 B | ||
|
Atrion Corporation
ATRI
|
243 K | - | - | $ 810 M | ||
|
electroCore
ECOR
|
7.44 M | $ 4.86 | 1.25 % | $ 26.8 K | ||
|
AngioDynamics
ANGO
|
183 M | $ 13.16 | - | $ 538 M | ||
|
The Cooper Companies
COO
|
8.24 B | $ 82.57 | -0.37 % | $ 16.4 B | ||
|
Glaukos Corporation
GKOS
|
462 M | $ 116.64 | 0.4 % | $ 5.65 B | ||
|
Masimo Corporation
MASI
|
1.05 B | $ 133.28 | -0.44 % | $ 7.1 B | ||
|
Haemonetics Corporation
HAE
|
2.45 B | $ 80.01 | -0.44 % | $ 4.03 B | ||
|
InfuSystem Holdings
INFU
|
48 M | $ 9.11 | 0.77 % | $ 188 M | ||
|
Predictive Oncology
POAI
|
-203 K | - | - | $ 32.4 M | ||
|
Intuitive Surgical
ISRG
|
16.5 B | $ 577.15 | -0.03 % | $ 205 B | ||
|
OraSure Technologies
OSUR
|
410 M | $ 2.43 | 2.53 % | $ 181 M | ||
|
Microbot Medical
MBOT
|
4.5 M | $ 2.18 | - | $ 22.2 M | ||
|
Milestone Scientific
MLSS
|
5.83 M | $ 0.29 | -0.48 % | $ 23.1 M | ||
|
Nephros
NEPH
|
8.36 M | $ 5.23 | 12.23 % | $ 54.3 M | ||
|
NeuroMetrix
NURO
|
14.3 M | - | 5.05 % | $ 9.02 M | ||
|
Envista Holdings Corporation
NVST
|
5.35 B | $ 22.0 | 0.59 % | $ 3.79 B | ||
|
Stereotaxis
STXS
|
21.9 M | $ 2.43 | -0.82 % | $ 196 M | ||
|
Pro-Dex
PDEX
|
36.6 M | $ 40.4 | -2.38 % | $ 133 M | ||
|
Pulse Biosciences
PLSE
|
44.4 M | $ 14.86 | 1.92 % | $ 714 M | ||
|
ResMed
RMD
|
3.36 B | $ 244.44 | -0.07 % | $ 35.7 B | ||
|
Repligen Corporation
RGEN
|
1.96 B | $ 165.66 | -0.42 % | $ 9.23 M | ||
|
BioLife Solutions
BLFS
|
349 M | $ 25.41 | -0.2 % | $ 1.17 B | ||
|
STAAR Surgical Company
STAA
|
397 M | $ 23.63 | -1.25 % | $ 1.16 B | ||
|
STERIS plc
STE
|
6.62 B | $ 255.68 | 0.11 % | $ 25.2 B | ||
|
Retractable Technologies
RVP
|
87.2 M | $ 0.82 | 0.01 % | $ 24.5 M | ||
|
Teleflex Incorporated
TFX
|
4.28 B | $ 122.33 | 0.03 % | $ 5.73 B | ||
|
Utah Medical Products
UTMD
|
128 M | $ 56.29 | -1.14 % | $ 204 M | ||
|
DENTSPLY SIRONA
XRAY
|
1.94 B | $ 11.22 | 1.26 % | $ 2.28 B | ||
|
West Pharmaceutical Services
WST
|
2.68 B | $ 276.66 | -0.3 % | $ 20.2 B |